These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25316796)

  • 1. Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host.
    Gerna G; Lilleri D; Fornara C; Bruno F; Gabanti E; Cane I; Furione M; Revello MG
    J Gen Virol; 2015 Feb; 96(Pt 2):360-369. PubMed ID: 25316796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular helper T-cells and virus-specific antibody response in primary and reactivated human cytomegalovirus infections of the immunocompetent and immunocompromised transplant patients.
    Bruno F; Fornara C; Zelini P; Furione M; Carrara E; Scaramuzzi L; Cane I; Mele F; Sallusto F; Lilleri D; Gerna G
    J Gen Virol; 2016 Aug; 97(8):1928-1941. PubMed ID: 27113912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary human cytomegalovirus infections: kinetics of ELISA-IgG and neutralizing antibody in pauci/asymptomatic pregnant women vs symptomatic non-pregnant subjects.
    Fornara C; Furione M; Lilleri D; Cane I; Revello MG; Zavattoni M; Gerna G
    J Clin Virol; 2015 Mar; 64():45-51. PubMed ID: 25728078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytomegalovirus (HCMV)-specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection against high HCMV viral load reactivation in solid-organ transplant recipients.
    Lilleri D; Zelini P; Fornara C; Zavaglio F; Rampino T; Perez L; Gabanti E; Gerna G
    J Med Virol; 2018 Oct; 90(10):1620-1628. PubMed ID: 29797330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.
    Gerna G; Percivalle E; Perez L; Lanzavecchia A; Lilleri D
    J Virol; 2016 Jul; 90(14):6216-6223. PubMed ID: 27122579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing and ELISA IgG antibodies to human cytomegalovirus glycoprotein complexes may help date the onset of primary infection in pregnancy.
    Lilleri D; Gerna G; Furione M; Zavattoni M; Spinillo A
    J Clin Virol; 2016 Aug; 81():16-24. PubMed ID: 27289427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host.
    Lilleri D; Zelini P; Fornara C; Comolli G; Revello MG; Gerna G
    Clin Immunol; 2009 Jun; 131(3):395-403. PubMed ID: 19268633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum antibody response to the gH/gL/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections.
    Genini E; Percivalle E; Sarasini A; Revello MG; Baldanti F; Gerna G
    J Clin Virol; 2011 Oct; 52(2):113-8. PubMed ID: 21820353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells are both required for prevention of HCMV disease in seropositive solid-organ transplant recipients.
    Gabanti E; Bruno F; Lilleri D; Fornara C; Zelini P; Cane I; Migotto C; Sarchi E; Furione M; Gerna G
    PLoS One; 2014; 9(8):e106044. PubMed ID: 25166270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative magnitude and kinetics of human cytomegalovirus-specific CD4⁺ and CD8⁺ T-cell responses in pregnant women with primary versus remote infection and in transmitting versus non-transmitting mothers: Its utility for dating primary infection in pregnancy.
    Fornara C; Furione M; Arossa A; Gerna G; Lilleri D
    J Med Virol; 2016 Jul; 88(7):1238-46. PubMed ID: 26680747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early neutralizing and glycoprotein B (gB)-specific antibody responses to human cytomegalovirus (HCMV) in immunocompetent individuals with distinct clinical presentations of primary HCMV infection.
    Alberola J; Tamarit A; Igual R; Navarro D
    J Clin Virol; 2000 Apr; 16(2):113-22. PubMed ID: 10720815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infection.
    Lilleri D; Kabanova A; Revello MG; Percivalle E; Sarasini A; Genini E; Sallusto F; Lanzavecchia A; Corti D; Gerna G
    PLoS One; 2013; 8(3):e59863. PubMed ID: 23555812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytomegalovirus end-organ disease is associated with high or low systemic viral load in preemptively treated solid-organ transplant recipients.
    Gerna G; Lilleri D; Furione M; Castiglioni B; Meloni F; Rampino T; Agozzino M; Arbustini E
    New Microbiol; 2012 Jul; 35(3):279-87. PubMed ID: 22842597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes.
    Shibamura M; Yoshikawa T; Yamada S; Inagaki T; Nguyen PHA; Fujii H; Harada S; Fukushi S; Oka A; Mizuguchi M; Saijo M
    Virol J; 2020 Aug; 17(1):120. PubMed ID: 32746933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dense Bodies of a gH/gL/UL128/UL130/UL131 Pentamer-Repaired Towne Strain of Human Cytomegalovirus Induce an Enhanced Neutralizing Antibody Response.
    Lehmann C; Falk JJ; Büscher N; Penner I; Zimmermann C; Gogesch P; Sinzger C; Plachter B
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients.
    Lilleri D; Gerna G; Bruno F; Draghi P; Gabanti E; Fornara C; Meloni F
    New Microbiol; 2013 Jul; 36(3):267-77. PubMed ID: 23912868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of a capture ELISA for IgM antibody to the human cytomegalovirus major DNA binding protein.
    Grazia Revello M; Percivalle E; Zannino M; Rossi V; Gerna G
    J Virol Methods; 1991 Dec; 35(3):315-29. PubMed ID: 1667791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response to human cytomegalovirus (HCMV) glycoprotein B (gB) in AIDS patients with HCMV end-organ disease.
    Alberola J; Domínguez V; Cardeñoso L; López-Aldeguer J; Blanes M; Estellés F; Ricart C; Pastor A; Igual R; Navarro D
    J Med Virol; 1998 Aug; 55(4):272-80. PubMed ID: 9661835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Strain-Specific Neutralizing Epitope on Glycoprotein H of Human Cytomegalovirus.
    Thomas M; Kropff B; Schneider A; Winkler TH; Görzer I; Sticht H; Britt WJ; Mach M; Reuter N
    J Virol; 2021 Aug; 95(18):e0065721. PubMed ID: 34160252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
    Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.